Edit Entry

Gary N. Schwartz, MD

Title(s):
Associate Professor of Medicine

Department(s):
Medicine

Education:
Stanford University, BA 1979Stanford University School of Medicine, MD 1985

Programs:
Norris Cotton Cancer Center

Websites:
http://dms.dartmouth.edu/nccc

Contact Information:

Dartmouth Medical School
HB 7500
Hanover NH 03755

Office: Rubin Building-Room 519
Phone: 603-650-6700
Fax: 603-650-0474
Email: gary.n.schwartz@hitchcock.org

Assistant: Nadine Lunt
Asst. Phone: 603-650-8898

Professional Interests:

Cancer chemotherapy and endocrine therapy for breast cancer, signal transduction pathways in breast cancer, and new drug development.

Grant Information:

ZD1839 (Iressa) in Tamoxifen-Resistant Metastatic Breast Cancer, Principal Investigator, (NCI-NIH)
S14 as a Therapeutic Targetin Breast Cancer, Co-investigator, (DOD)

Courses Taught:

None

Selected Publications:
 

  • Pendyala L. Schwartz G. Smith P. Zdanowicz J. Murphy M. Hausheer F Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy. Cancer Chemotherapy & Pharmacology. 51(5):376-84, 2003 May (view details on MedLine)

  • Schwartz GN, Pendyala L, Kindler H, Meropol N, Perez R, Raghavan D, and Creaven P The clinical development of paclitaxel and the paclitaxel/carboplatin combination. Eur J Cancer 34(10):1543-1548, 1998 (view details on MedLine)

  • Schwartz GN, Teicher BA, Eder JP, Korbut T, Holden SA, Ara G, Herman TS Modulation of antitumor alkylating agents by novobiocin, topotecan, and lonidamine. Cancer Chemotherapy and Pharmacology, 1993, 32:455-62 (view details on MedLine)

    		•